» Articles » PMID: 38775020

Reproductive Factors and Thyroid Cancer Risk: The Multiethnic Cohort Study

Overview
Date 2024 May 22
PMID 38775020
Authors
Affiliations
Soon will be listed here.
Abstract

Women are three times more likely to be diagnosed with thyroid cancer than men, with incidence rates per 100,000 in the United States of 20.2 for women and 7.4 for men. Several reproductive and hormonal factors have been proposed as possible contributors to thyroid cancer risk, including age at menarche, parity, age at menopause, oral contraceptive use, surgical menopause, and menopausal hormone therapy. Our study aimed to investigate potential reproductive/hormonal factors in a multiethnic population. Risk factors for thyroid cancer were evaluated among female participants ( = 118,344) of the Multiethnic Cohort Study. The cohort was linked to Surveillance, Epidemiology, and End Results cancer incidence and statewide death certificate files in Hawaii and California, with 373 incident papillary thyroid cancer cases identified. Exposures investigated include age at menarche, parity, first pregnancy outcome, birth control use, and menopausal status and type. Multivariable Cox proportional hazards models were used to obtain relative risk (RR) of papillary thyroid cancer and their 95% confidence intervals (CI). Covariates included age, race and ethnicity, reproductive history, body size, smoking, and alcohol consumption. We observed a statistically significant increased risk of papillary thyroid cancer for oophorectomy (adjusted RR 1.58, 95% CI: 1.26, 1.99), hysterectomy (adjusted RR 1.65, 95% CI: 1.33, 2.04), and surgical menopause (adjusted RR 1.55, 95% CI: 1.22, 1.97), and decreased risk for first live birth at ≤20 years of age versus nulliparity (adjusted RR 0.66, 95% CI: 0.46, 0.93). These associations did not vary by race and ethnicity ( het > 0.44). The reproductive risk factors for papillary thyroid cancer reported in the literature were largely confirmed in all racial and ethnic groups in our multiethnic population, which validates uniform obstetric and gynecological practice.

Citing Articles

The risk of thyroid cancer after hysterectomy and oophorectomy: a meta-analysis.

Fu S, Lu Y, Liu Y Front Oncol. 2024; 14:1446303.

PMID: 39381044 PMC: 11460577. DOI: 10.3389/fonc.2024.1446303.

References
1.
Sakoda L, Horn-Ross P . Reproductive and menstrual history and papillary thyroid cancer risk: the San Francisco Bay Area thyroid cancer study. Cancer Epidemiol Biomarkers Prev. 2002; 11(1):51-7. View

2.
Kolonel L, Hankin J, Wilkens L, FUKUNAGA F, Hinds M . An epidemiologic study of thyroid cancer in Hawaii. Cancer Causes Control. 1990; 1(3):223-34. DOI: 10.1007/BF00117474. View

3.
Schubart J, Eliassen A, Schilling A, Goldenberg D . Reproductive Factors and Risk of Thyroid Cancer in Women: An Analysis in the Nurses' Health Study II. Womens Health Issues. 2021; 31(5):494-502. DOI: 10.1016/j.whi.2021.03.008. View

4.
Kolonel L, Henderson B, Hankin J, Nomura A, Wilkens L, Pike M . A multiethnic cohort in Hawaii and Los Angeles: baseline characteristics. Am J Epidemiol. 2000; 151(4):346-57. PMC: 4482109. DOI: 10.1093/oxfordjournals.aje.a010213. View

5.
Rahbari R, Zhang L, Kebebew E . Thyroid cancer gender disparity. Future Oncol. 2010; 6(11):1771-9. PMC: 3077966. DOI: 10.2217/fon.10.127. View